clinical-gastroentrology-2016_posters-accepted-abstracts

8 / 16

Page 48
Clinical Gastroenterology 2016
October 03-05, 2016
Volume 6, Issue 6(Suppl) J Gastrointest Dig Syst
ISSN:2161-069X JGDS, an open access journal
conferenceseries .com
October 03-05, 2016 Toronto, Canada
8th International Conference on
Clinical Gastroenterology & Hepatology
J Gastrointest Dig Syst 2016, 6:6(Suppl)
Whole gut ischemia: Diagnostic and management challenges
Oumer Jemal Yenus
Bahir Dar University, Ethiopia
Gut ischemia is not a common condition. It occurs in patients who are on certain medications or those who have cardiac
abnormalities. It affects largely on the major vessels supplying part of the gut and that part will be ischemic. Here, we
present a case of whole gut ischemia where all parts of the gut from the stomach to the rectum are involved by the insult which
is a rare presentation. All major vessels are not palpable. Its presentation, diagnosis and management will be discussed in detail.
Body mass index may predict the long-term outcomes of advanced gastric cancer
Beom Jin Kim, Jae G Kim, Kyung Cheon Chi, Jung Min Park, Mi Kyoung Kim and In Kyu Hwang
Chung-Ang University, South Korea
Objectives:Radical gastrectomy followedby adjuvant chemotherapy for advanced gastric cancer brings about serious nutritional
impairment. Recent studies have shown an association between body mass index (BMI) and perioperative outcomes of gastric
cancer. However, little is known about the association between BMI and long-term outcomes of advanced gastric cancer. Our
study evaluated the clinical impact of BMI on the long-term outcomes of gastric cancer staged at II and III, treated by radical
gastrectomy followed by adjuvant chemotherapy.
Methods: We analyzed a total of 211 cases of advanced gastric cancer stage II and III between January 2005 and December
2010 at Chung-Ang University Hospital. The patients were divided into 4 groups according to BMI; underweight, normal,
overweight and obese. In addition, they were divided into two groups (BMI-High vs. BMI-Low). We assessed age, sex, tumor
location, lymph node involvement, operation method, initial cancer stage, recurrence, and survival (overall survival and
disease free survival) between two groups.
Results: We classified them into 4 groups according to BMI; underweight, normal, overweight, and obese. There was no
difference in overall survival between normal, overweight, and obese group. However, there was significant difference between
underweight group and the other groups. As for disease free survival, similar findings were observed. Among 211 patients,
154 patients (72.9%) were included in BMI-L (body mass index <25), whereas 57 patients (27.1%) in BMI-H (body mass index
≥25). There was no difference in age, sex, tumor location, stage, lymph node involvement, operation method, recurrence, and
cancer-related death between two groups. When classified into 4 groups as stage II in BMI-H, stage II in BMI-L, stage III in
BMI-H, and stage III in BMI-L, overall survival showed significant difference in stage, however, no difference between BMI-H
and BMI-L was observed. Disease free survival showed no significant difference in stage and BMI, especially, no significant
difference between stage II in BMI-L and stage III in BMI-H.
Conclusion: Our findings suggest that preoperative BMI may predict the long term outcomes of advanced gastric cancer after
radical surgery and chemotherapy.